Nutritional improvement of metabolic syndrome parametersin immature fructose-fed wild-type mice

Molecular Medicine Reports

Volumn 4, Issue 6, 2011, Pages 1053-1059

  Cha, J C ^a   Ivanov, V ^a   Roomi, M W ^a   Kalinovsky, T ^a   Niedzwiecki, Aleksandra ^a   Rath, M ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

C57 bl6 j wild type mice; Diabetes nutrient mix; Fructosamine; Fructose diet; Lipid profile; Metabolic syndrome parameters; Metformin; Systolic blood pressure

Indexed keywords

CHOLESTEROL; CREATININE; FRUCTOSAMINE; FRUCTOSE; GLUCOSE; INSULIN; LIPOPROTEIN; METFORMIN; METHYLGLYOXAL;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC DIET; DIABETIC NUTRIENT MIXTURE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE URINE LEVEL; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC REGULATION; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL HEALTH; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; URINALYSIS; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DISEASE MODELS, ANIMAL; FRUCTOSAMINE; FRUCTOSE; HYPOGLYCEMIC AGENTS; MALE; METABOLIC SYNDROME X; METFORMIN; MICE; MICE, INBRED C57BL;

MUS;

EID: 80053115426     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.562     Document Type: Article

References (34)

1. Meigs JB: Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009. Diabetes Care 33: 1865-1871, 2010.
2. Cavender MA and Lincoff AM: Therapeutic potential of aleglitazar, a new dual PPAR-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus. Am J Cardiovasc Drugs 10: 209-216, 2010.
3. Perez-Pozo SE, Schold J, Nakagawa T, Sánchez-Lozada LG, Johnson RJ and Lillo JL: Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes 34: 454-461, 2010.
4. Farah V, Elased KM, Chen Y, Key MP, Cunha TS, Irigoyen MC and Morris M: Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci 130: 41-50, 2006. (Pubitemid 44750860)
5. Rabbani N and Thornalley PJ: Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress. Biochem Soc Trans 36: 1045-1050, 2008.
6. Hofmann SM, Dong HJ, Li Z, Cai W, Altomonte J, Thung SN, Zeng F, Fisher EA and Vlassara H: Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 51: 2082-2089, 2002. (Pubitemid 34729011)
7. Armbruster D: Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 33: 2135-2163, 1987.
8. Baker J, O'Connor JP, Metcalf PA, Lawson MR and JohnsonRN: Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J (Clin Res Ed) 287: 863-867, 1983. (Pubitemid 13004993)
9. Van Dieren S, Beulens JW, Van der Schouw YT, Grobbee DE and Neal B: The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 17 (Suppl1): S3-S8, 2010.
10. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, WuM, Ventre J, Doebber T, Fujii N, et al: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest108: 1167-1174, 2001. (Pubitemid 32995375)
11. Wang X, Liu X, Zhan Y, Lavallie ER, Diblasio-Smith L, Collins-Racie L, Mounts WM, Rutkowski JL, Xu X, GoltsmanI, etal: Pharmacogenomic, physiological, and biochemical investigations on safety and efficacy biomarkers associated with the peroxisome proliferator-activated receptor-gamma activator rosiglitazone in rodents: a translational medicine investigation. J Pharmcol Exp Ther 334: 820-829, 2010.
12. Chen Y, Zhou K, Wang R, Liu Y, Kwak YD, Ma T, ThompsonRC, Zhao Y, Smith L, Gasparini L, et al: Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Proc Natl Acad USA 106: 3907-3912, 2009.
13. Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, MarchesiF, Galli-Kienle M, Pozza G and Alberti KG: Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 24: 875-880, 2001. (Pubitemid 33636062)
14. Sim MK, Wong YC, Xu XG, Sim SZ and Tsi D: Hypoglycemic action of chicken meat extract in type-2 diabetic KKAy mice and GK rats. Biosci Biotechnol Biochem 73: 2583-2588, 2009.
15. González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA, Ramírez-Ramírez V and Ramos-Zavala MG: Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naïve patients with type 2 diabetes. Eur J Nutr50: 145-149, 2011.
16. Arora S, Lidor A, Abularrage CJ, Weiswasser JM, Nylen E, Kellicut D and Sidawy AN: Thiamine (vitamin B1) improves endothelium-dependent vasodilatation in the presence of hyperglycemia. Ann Vasc Surg 20: 653-658, 2006. (Pubitemid 44953082)
17. Cunningham JJ, Mearkle PL and Brown RG: Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus. J Am Coll Nutr 134: 344-350, 1994. (Pubitemid 24251141)
18. Zanoni JN, Pereira RVF and De Freitas P: Effect of the ascorbic acid treatment on the NADHd-positive myenteric neurons of diabetic rats proximal colon. Braz Arch Biol Technol 50: 31-38, 2007. (Pubitemid 46423019)
19. Zygmunt K, Flaubert B, MacNeil J and Tsiani E: Naringenin, a citrus bioflavonoid, increases muscle cell glucose uptake via AMPK. Biochem Biophys Res Commun 398: 178-183, 2010.
20. Urios P, Grigorova-Borsos AM and Sternberg M: Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure. Eur J Nutr 46: 139-146, 2007. (Pubitemid 46486620)
21. Peng X, Cheng KW, Ma J, Chen B, Ho CT, Lo C, Chen F and WangM: Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J Agric Food Chem 56: 1907-1911, 2008. (Pubitemid 351497845)
22. Tanaka M, Misawa E, Ito Y, Habara N, Nomaguchi K, Yamada M, Toida T, Hayasawa H, Takase M, Inagaki M, et al: Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull 29: 1418-1422, 2006.
23. Suwannaphet W, Meeprom A, Yibchok-Anun S and AdisakwattanaS: Preventive effect of grape seed extract against high-fructose diet-induced insulin resistance and oxidative stress in rats. Food Chem Toxicol 48: 1853-1857, 2010.
24. Liu J, Sun H, Duan W, Mu D and Zhang L: Maslinic acid reduces blood glucose in KK-Ay mice. Biol Pharm Bull 30: 2075-2078, 2007. (Pubitemid 350097042)
25. Yi X and Maeda N: Alpha-lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes 55: 2238-2244, 2006. (Pubitemid 44743620)
26. Oron-Herman M, Kamari Y, Grossman E, Yeger G, Peleg E, ShabtayZ, Shamisss A and Sharabi Y: Metabolic syndrome: comparison of the two commonly used animal models. Am J Hypertens 21: 1018-1022, 2008.
27. Siscovick DS, Sotoodehnia N, Rea TD, Raghunathan TE, JouvenX and Lemaitre RN: Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev Endocr Metab Disord 11: 53-59, 2010.
28. Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P and Ibrahim SA: Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41 (Suppl 2): 36-41, 1992.
29. Pedchenko VK, Chetyrkin SV, Chuang P, Ham AJ, SaleemMA, Mathieson PW, Hudson BG and Voziyan PA: Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic neuropathy. Diabetes 54: 2952-2960, 2005. (Pubitemid 41401092)
30. Lankin VZ, Tikhaze AK, Kapel'ko VI, Shepel'kova GS, ShumaevKB, Panasenko OM, Konovalova GG and BelenkovYN: Mechanisms of oxidative modification of low density lipoproteins under conditions of oxidative and carbonyl stress. Biochemistry (Mosc) 72: 1081-1090, 2007. (Pubitemid 350022591)
31. Nyengaard JR, Chang K, Berhorst S, Reiser KM, WilliamsonJR and Tilton RG: Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats. Diabetes 46: 94-106, 1997. (Pubitemid 27009956)
32. Degenhardt TP, Fu MX, Voss E, Reiff K, Neidlein R, StreinK, Thorpe SR, Baynes JW and Reiter R: Aminoguanidine inhibits albuminuria, but not the formation of advance glycation end-products in skin collagen of diabetic rats. Diabetes Res Clin Pract 43: 81-89, 1999. (Pubitemid 29155652)
33. Hujberts MS, Wolffenbuttel BH, Crijns FR, Nieuwenhuijzen Kruseman AC, Bemelmans MH and Strujiker Boudier HA: Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats. Diabetologia 37: 10-14, 1994. (Pubitemid 24044701)
34. Thung PJ: Physiological proteinuria in mice. Acta Physiol Pharmacol Neerl 10: 248-261, 1962.